| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |